Summary
This filing is an amendment to a previous 8-K report by Cencora, Inc. (formerly AmerisourceBergen Corporation). The primary purpose of this amendment is to provide the Distributor Settlement Agreement as an exhibit. This agreement, previously announced on February 25, 2022, is a significant development concerning the resolution of a substantial majority of opioid-related lawsuits filed against Cencora, Cardinal Health, and McKesson by U.S. states, territories, and local governmental entities. The agreement became effective on April 2, 2022. While the core terms were previously disclosed, the filing of the full agreement as an exhibit allows investors to review the detailed terms of this material resolution. The settlement addresses a major legal liability for the company, and its effective date marks a critical milestone in resolving these ongoing opioid-related litigation matters.
Key Highlights
- 1Amendment to a prior 8-K filing to include the Distributor Settlement Agreement as an exhibit.
- 2The Distributor Settlement Agreement is a material definitive agreement related to opioid-related lawsuits.
- 3The agreement involves Cencora (formerly AmerisourceBergen Corporation), Cardinal Health, and McKesson as Settling Distributors.
- 4The settlement aims to resolve a substantial majority of lawsuits filed by U.S. states, territories, and local governmental entities.
- 5The Distributor Settlement Agreement became effective on April 2, 2022.
- 6Exhibit C (Litigating Subdivisions List) and Exhibit G (Subdivisions Eligible to Receive Direct Allocations) remain subject to change.